March 8, 2011 – RaySearch Laboratories has entered into an exclusive license agreement with Princess Margaret Hospital (PMH) in Toronto, Canada, regarding deformable image registration technology. RaySearch and PMH have a long-standing research collaboration focused on strategies and tools for adaptive radiation therapy.
March 7, 2011 – A medical office electronic medical record (EMR) has received Complete EHR Ambulatory certification. Medstreaming’s EMR enables providers to demonstrate stage 1 meaningful use and qualify for funding under the American Recovery and Reinvestment Act (ARRA).
March 7, 2011 – Two new imaging solutions for mammography and interventional radiology were announced at the 2011 European Congress of Radiology (ECR). Mammo PlusViewCAD, from ContextVision, addresses current limitations of X-ray image diagnosis for the detection of breast cancer.
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
December 7, 2010 — To help clinicians better understand meaningful use in imaging, TeraMedica has created the Vendor Neutral Archive (VNA) University online educational program.
March 7, 2011 - Totoku has selected Matrox Xenia Pro display controller boards to bundle with its next-generation medical LCD displays. The parts will be used on the MS53i2 and MS51i2 5MP displays.
March 7, 2011 – A strategic alliance has been announced that will give an Illinois radiology practice access to subspecialists and next-generation technology. Lakeland Radiologists will merge with an affiliated medical practice of Virtual Radiologic (vRad) and will be called Lakeland Radiology Alliance.
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
March 7, 2011 – Last week Medtronic Inc. cancelled its five contracts with Novation LLC, one of the largest U.S. group purchasing organizations (GPOs), which previously represented $2 billion. The contracts included reduced price, large group purchases of cardiovascular and orthopedic devices.
March 7, 2011 – Accuray, a global leader in the field of radiosurgery, and TomoTherapy Inc., creator of radiation therapy solutions for cancer care, today announced they signed a agreement under which Accuray will acquire TomoTherapy for $4.80 per share in cash and stock, or a total of approximately $277 million.
March 4, 2011 – For the first time, quantitative—not qualitative—data analysis has demonstrated that time-of-flight (TOF) positron emission tomography (PET) scans can improve cancer detection.
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
March 4, 2011 – Digital image detectors and X-ray tubes for fluoroscopy, angiography, cardiology and cone-beam CT imaging will be on display at the European Congress of Radiology (ECR) in Vienna. Varian will showcase several products, including its PaxScan digital image detectors.
March 4, 2011 – The first clinical results from a research project focused on spectral (color) mammography shows promising diagnostic benefits for breast cancer. Published in the February issue of Radiology, the results will be presented at the 2011 European Congress of Radiology (ECR) in Vienna, March 5.
March 4, 2011 – A 3-D mammography system and other ready-to-market technologies in women’s imaging will be showcased at the National Interdisciplinary Breast Center Conference (NCBC) in Las Vegas.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
March 4, 2011 – A new generation of a mobile C-arm has been launched, offering outstanding imaging and a liquid cooling system to allow use over an almost unlimited period of time. The Vision RFD mobile C-arm, from Ziehm, is an alternative to fixed installations in hybrid operating rooms (ORs), especially for hospitals with space and budgetary constraints.
March 4, 2011 – The U.S. Food and Drug Administration (FDA) recently cleared two new magnetic resonance (MR) systems. Approximately 180 Optima MR360 1.5 Tesla and Brivo MR355 1.5 Tesla scanners, from GE Healthcare, have been ordered by hospitals and imaging centers worldwide.
March 3, 2011 – A positron emission mammography (PEM) scanner has been launched at two radiology conferences in Vienna. The Naviscan PEM scanner can reduce unnecessary biopsies by providing superior specificity, and has the ability to differentiate between benign and malignant lesions.
Sectra will highlight its latest Web-based Breast Imaging picture archiving and communication system (PACS) at the National Interdisciplinary Breast Center Conference. The PACS enables physicians to view breast studies across multiple modalities from within a single workstation.
March 3, 2011 – The U.S. Food and Drug Administration (FDA) has cleared a whole-body positron emission tomography (PET) application. Xpress.PET, by UltraSpect, enables reduced dose and acquisition time without compromising image quality. The benefits of application, which is based on the company’s Wide-Beam Reconstruction (WBR) technology in whole body PET/CT scanning include:
March 3, 2011 – Philips has donated two ultrasound systems to Imaging the World (ITW), a non-profit organization, to help improve healthcare in Uganda. In addition to the two CX50 CompactXtreme portable ultrasound systems, Philips will provide technical training and $100,000 in financial support.
March 2, 2011 – America’s hospitals and health systems are focusing more on renovation or expansion than new construction, according to a survey from Health Facilities Management magazine and the American Society for Healthcare Engineering (ASHE). In fact, renovation or expansion accounted for 73 percent of construction projects at hospitals responding to the survey.
March 1, 2011 – The U.S. Court of Appeals for the Federal Circuit has ruled in favor of Hologic and against SenoRX regarding patent infringement involving breast brachytherapy systems. The court reversed previous decisions reached by the U.S. District Court for the Northern District of California, which were in favor of SenoRx.